欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1800/001
药品名称
MOVPREP
活性成分
macrogol 100.0 g
potassium chloride 1.01 g
sodium sulfate 7.5 g
sodium chloride 2.69 g
剂型
Powder for oral solution
上市许可持有人
Norgine BV
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Denmark (DK)
Moviprep
Austria (AT)
MOVIPREP Pulver zur Herstellung einer Lösung zum Einnehmen
France (FR)
Spain (ES)
Portugal (PT)
Romania (RO)
Moviprep pulbere pentru solutie orala
Slovakia (SK)
MOVIPREP
Slovenia (SI)
Malta (MT)
Latvia (LV)
Czechia (CZ)
MOVIPREP® Prášek pro přípravu perorálního roztoku
Bulgaria (BG)
Moviprep
Finland (FI)
Estonia (EE)
Lithuania (LT)
Moviprep milteliai geriamajam tirpalui
Luxembourg (LU)
Italy (IT)
Poland (PL)
MOVIPREP
Norway (NO)
Iceland (IS)
Ireland (IE)
Netherlands (NL)
Moviprep
Belgium (BE)
Germany (DE)
Moviprep, Pulver zur Herstellung einer Lösung zum Einnehmen
United Kingdom (Northern Ireland) (XI)
PL 20142/0005 - 0041
许可日期
2008/04/05
最近更新日期
2023/11/30
药物ATC编码
A06AD13 sodium sulfate
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PAR
|
con2033924.pdf
Date of last change:2016/01/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase